1. DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn's and Colitis Organisation study. (16th January 2018) Authors: Kopylov, U; Verstockt, B; Biedermann, L; Sebastian, S; Pugliese, D; Sonnenberg, E; Steinhagen, P R; Arebi, N; Ron, Y; Kucharzik, T; Roblin, X; Ungar, B; Bar-Gil Shitrit, A; Ardizzone, S; Molander, P; Coletta, M; Peyrin-Biroulet, L; Bossuyt, P; Avni-Biron, I; Tsoukal, E I Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP018 Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn's disease. (16th January 2018) Authors: Creyns, B; Verstockt, B; Cremer, J; Ferrante, M; Vermeire, S; Jan, C; Van Assche, G; Breynaert, C Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP020 Thiopurine monotherapy still has a place in the treatment of patients with mild-to-moderate Crohn's disease in the biological era. (16th January 2018) Authors: Verstockt, B; Boets, L; Van Assche, G; Vermeire, S; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP05 Single-cell RNAseq temporal analysis of ulcerative colitis patients undergoing tofacitinib treatment reveals a shift in myeloid cells towards pro-inflammatory phenotypes in refractory patients. (30th January 2023) Authors: Melón-Ardanaz, E; Veny, M; Corraliza, A M; Garrido-Trigo, A; Esteller, M; Rodrigo, M; Verstockt, B; Vermeire, S; Masamunt, M C; Giner, Á; Ordás, I; Fernández-Clotet, A; Ricart, E; Panés, J; Salas, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP07 Ulcerative Colitis associated single nucleotide polymorphisms found in transcription factor binding sites effect key pathogenesis pathways and facilitate patient stratification. (27th May 2021) Authors: Modos, D; Brooks-Warburton, J; Sudhakar, P; Madgwick, M; Fazekas, D; Szalay-Beko, M; Thomas, J P; Verstockt, B; Watson, A; Tremelling, M; Parkes, M; Vermeire, S; Bender, A; Carding, S R; Korcsmaros, T Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S045 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DOP08 Serum proteomics predict endoscopic remission in patients with Crohn's Disease. (27th May 2021) Authors: Alsoud, D; Sudhakar, P; Sabino, J; Ferrante, M; Verstockt, B; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S046 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DOP08 Transcriptional signatures of blood derived immune cells associated with disease location-based heterogeneity in IBD. (21st January 2022) Authors: Sudhakar, P; Verstockt, B; Cremer, J; Verstockt, S; Sabino, J; Ferrante, M; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DOP09 Eosinophils exert a pro-inflammatory role in a chronic DSS colitis model without an impact on fibrosis. (30th January 2023) Authors: Jacobs, I; Deleu, S; Cremer, J; De Hertogh, G; Vermeire, S; Breynaert, C; Vanuytsel, T; Verstockt, B Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DOP17 Evaluating segmental healing with the modified Mayo endoscopic score (MMES) has a clear additional value in predicting long-term outcome in patients with Ulcerative Colitis: Results from a prospective cohort study. (21st January 2022) Authors: Lenfant, M; Verstockt, B; Sabino, J; Vermeire, S; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn's Disease. (27th May 2021) Authors: Sudhakar, P; Andrighetti, T; Verstockt, S; Caenepeel, C; Ferrante, M; Sabino, J; Verstockt, B; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗